An international team of researchers led by Lancaster University has made a promising breakthrough in the development of ...

AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.

Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...

“This research is taking promising steps towards a new one-of-a-kind therapy which targets tau, a damaging protein in the ...

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that works on ...

In a promising breakthrough, an international team of researchers from the UK, US, and Japan has developed a new Alzheimer’s drug that effectively prevents the build-up of Tau proteins -- a key driver ...

For the first time, scientists have developed a drug that works on both major aggregation-promoting "hotspots" of the Tau protein - addressing a critical gap in current treatments.

In people with Alzheimer's disease, they clump together, starve brain cells of nutrients and slow down signals in the organ ...

Alzheimer’s breakthrough after drug treatment success - Study found that the medication, called RI-AG03, was effective at ...

Researchers from a study funded by the Alzheimer’s Society of UK have developed a new drug known as RI-AG03 that they say can ...